Thursday, 18 October 2018

FOX BIZ NEWS: Novartis boosts outlook, announces $2.1B Endocyte deal


Novartis boosts outlook, announces $2.1B Endocyte deal



The Swiss healthcare company is paying 24 dollars per share in cash for Endocyte.

via FOX BUSINESS NEWS https://ift.tt/2yl71n6

Labels: ,

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home